Recent interview with Moderna's CEO:
"As you were saying, part of this is forward-looking because you have this platform technology [mRNA] that you feel is going to produce more vaccines. What’s next?
Flu is the next one. It could be as early as 2023. And on RSV [respiratory syncytial virus], there’s been some interesting news in the field because the world has needed an RSV vaccine for decades."
https://www.wsj.com/articles/modernas-ceo-on-its-new-covid-19-booster-prospects-for-cancer-vaccines-11663339811?st=p9hfwwo5y886buu&reflink=desktopwebshare_permalink
I will resolve "Yes" if any RSV mRNA vaccine is approved or given an emergency use authorization by the FDA, and it is available for the general public, for a specific age-group (e.g. 65 years or older) or for a group with certain health conditions (e.g. moderately or severely immunocompromised).
Oct 27, 10:30am: Will an mRNA RSV vaccine be available by 2025? → Will an mRNA RSV vaccine be available by the end of 2025?
1,000🏅 Top traders
| # | Name | Total profit |
|---|---|---|
| 1 | Ṁ296 | |
| 2 | Ṁ219 | |
| 3 | Ṁ10 | |
| 4 | Ṁ9 | |
| 5 | Ṁ9 |